Hereditary Transthyretin Amyloidosis Market
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral
1.2.3 Subcutaneous Injection
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Perspective (2017-2028)
2.2 Hereditary Transthyretin Amyloidosis (HATTR) Growth Trends by Region
2.2.1 Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Hereditary Transthyretin Amyloidosis (HATTR) Historic Market Size by Region (2017-2022)
2.2.3 Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Region (2023-2028)
2.3 Hereditary Transthyretin Amyloidosis (HATTR) Market Dynamics
2.3.1 Hereditary Transthyretin Amyloidosis (HATTR) Industry Trends
2.3.2 Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers
2.3.3 Hereditary Transthyretin Amyloidosis (HATTR) Market Challenges
2.3.4 Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Revenue
3.1.1 Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Revenue (2017-2022)
3.1.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Players (2017-2022)
3.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hereditary Transthyretin Amyloidosis (HATTR) Revenue
3.4 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Concentration Ratio
3.4.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hereditary Transthyretin Amyloidosis (HATTR) Revenue in 2021
3.5 Hereditary Transthyretin Amyloidosis (HATTR) Key Players Head office and Area Served
3.6 Key Players Hereditary Transthyretin Amyloidosis (HATTR) Product Solution and Service
3.7 Date of Enter into Hereditary Transthyretin Amyloidosis (HATTR) Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hereditary Transthyretin Amyloidosis (HATTR) Breakdown Data by Type
4.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Historic Market Size by Type (2017-2022)
4.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Type (2023-2028)
5 Hereditary Transthyretin Amyloidosis (HATTR) Breakdown Data by Application
5.1 Global Hereditary Transthyretin Amyloidosis (HATTR) Historic Market Size by Application (2017-2022)
5.2 Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2017-2028)
6.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
6.2.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2017-2022)
6.2.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2023-2028)
6.2.3 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type (2017-2028)
6.3 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
6.3.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2017-2022)
6.3.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2023-2028)
6.3.3 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application (2017-2028)
6.4 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
6.4.1 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2017-2022)
6.4.2 North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2017-2028)
7.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
7.2.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2017-2022)
7.2.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2023-2028)
7.2.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type (2017-2028)
7.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
7.3.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2017-2022)
7.3.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2023-2028)
7.3.3 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application (2017-2028)
7.4 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
7.4.1 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2017-2022)
7.4.2 Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2017-2028)
8.2 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
8.2.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type (2017-2028)
8.3 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
8.3.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application (2017-2028)
8.4 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region
8.4.1 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2017-2028)
9.2 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
9.2.1 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2017-2022)
9.2.2 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2023-2028)
9.2.3 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type (2017-2028)
9.3 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
9.3.1 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2017-2022)
9.3.2 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2023-2028)
9.3.3 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application (2017-2028)
9.4 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
9.4.1 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2017-2022)
9.4.2 Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size (2017-2028)
10.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type
10.2.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type (2017-2028)
10.3 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application
10.3.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application (2017-2028)
10.4 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country
10.4.1 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.1.4 Pfizer Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022)
11.1.5 Pfizer Recent Developments
11.2 Alnylam Pharmaceuticals
11.2.1 Alnylam Pharmaceuticals Company Details
11.2.2 Alnylam Pharmaceuticals Business Overview
11.2.3 Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.2.4 Alnylam Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022)
11.2.5 Alnylam Pharmaceuticals Recent Developments
11.3 Akcea Therapeutics
11.3.1 Akcea Therapeutics Company Details
11.3.2 Akcea Therapeutics Business Overview
11.3.3 Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.3.4 Akcea Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022)
11.3.5 Akcea Therapeutics Recent Developments
11.4 Prothena
11.4.1 Prothena Company Details
11.4.2 Prothena Business Overview
11.4.3 Prothena Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.4.4 Prothena Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022)
11.4.5 Prothena Recent Developments
11.5 Lonis Pharmaceuticals
11.5.1 Lonis Pharmaceuticals Company Details
11.5.2 Lonis Pharmaceuticals Business Overview
11.5.3 Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.5.4 Lonis Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022)
11.5.5 Lonis Pharmaceuticals Recent Developments
11.6 Eidos Therapeutics
11.6.1 Eidos Therapeutics Company Details
11.6.2 Eidos Therapeutics Business Overview
11.6.3 Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.6.4 Eidos Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022)
11.6.5 Eidos Therapeutics Recent Developments
11.7 Corino Therapeutics Inc
11.7.1 Corino Therapeutics Inc Company Details
11.7.2 Corino Therapeutics Inc Business Overview
11.7.3 Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Introduction
11.7.4 Corino Therapeutics Inc Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022)
11.7.5 Corino Therapeutics Inc Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Oral
Table 3. Key Players of Subcutaneous Injection
Table 4. Key Players of Others
Table 5. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Region (2017-2022)
Table 9. Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Region (2023-2028)
Table 11. Hereditary Transthyretin Amyloidosis (HATTR) Market Trends
Table 12. Hereditary Transthyretin Amyloidosis (HATTR) Market Drivers
Table 13. Hereditary Transthyretin Amyloidosis (HATTR) Market Challenges
Table 14. Hereditary Transthyretin Amyloidosis (HATTR) Market Restraints
Table 15. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Share by Players (2017-2022)
Table 17. Global Top Hereditary Transthyretin Amyloidosis (HATTR) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Transthyretin Amyloidosis (HATTR) as of 2021)
Table 18. Ranking of Global Top Hereditary Transthyretin Amyloidosis (HATTR) Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Hereditary Transthyretin Amyloidosis (HATTR) Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hereditary Transthyretin Amyloidosis (HATTR) Product Solution and Service
Table 22. Date of Enter into Hereditary Transthyretin Amyloidosis (HATTR) Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Type (2017-2022)
Table 26. Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Market Share by Type (2023-2028)
Table 28. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Share by Application (2017-2022)
Table 30. Global Hereditary Transthyretin Amyloidosis (HATTR) Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Hereditary Transthyretin Amyloidosis (HATTR) Revenue Share by Application (2023-2028)
Table 32. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size by Country (2023-2028) & (US$ Million)
Table 62. Pfizer Company Details
Table 63. Pfizer Business Overview
Table 64. Pfizer Hereditary Transthyretin Amyloidosis (HATTR) Product
Table 65. Pfizer Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022) & (US$ Million)
Table 66. Pfizer Recent Developments
Table 67. Alnylam Pharmaceuticals Company Details
Table 68. Alnylam Pharmaceuticals Business Overview
Table 69. Alnylam Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product
Table 70. Alnylam Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022) & (US$ Million)
Table 71. Alnylam Pharmaceuticals Recent Developments
Table 72. Akcea Therapeutics Company Details
Table 73. Akcea Therapeutics Business Overview
Table 74. Akcea Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product
Table 75. Akcea Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022) & (US$ Million)
Table 76. Akcea Therapeutics Recent Developments
Table 77. Prothena Company Details
Table 78. Prothena Business Overview
Table 79. Prothena Hereditary Transthyretin Amyloidosis (HATTR) Product
Table 80. Prothena Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022) & (US$ Million)
Table 81. Prothena Recent Developments
Table 82. Lonis Pharmaceuticals Company Details
Table 83. Lonis Pharmaceuticals Business Overview
Table 84. Lonis Pharmaceuticals Hereditary Transthyretin Amyloidosis (HATTR) Product
Table 85. Lonis Pharmaceuticals Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022) & (US$ Million)
Table 86. Lonis Pharmaceuticals Recent Developments
Table 87. Eidos Therapeutics Company Details
Table 88. Eidos Therapeutics Business Overview
Table 89. Eidos Therapeutics Hereditary Transthyretin Amyloidosis (HATTR) Product
Table 90. Eidos Therapeutics Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022) & (US$ Million)
Table 91. Eidos Therapeutics Recent Developments
Table 92. Corino Therapeutics Inc Company Details
Table 93. Corino Therapeutics Inc Business Overview
Table 94. Corino Therapeutics Inc Hereditary Transthyretin Amyloidosis (HATTR) Product
Table 95. Corino Therapeutics Inc Revenue in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022) & (US$ Million)
Table 96. Corino Therapeutics Inc Recent Developments
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Type: 2021 VS 2028
Figure 2. Oral Features
Figure 3. Subcutaneous Injection Features
Figure 4. Others Features
Figure 5. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Application: 2021 VS 2028
Figure 6. Hospital Case Studies
Figure 7. Clinic Case Studies
Figure 8. Others Case Studies
Figure 9. Hereditary Transthyretin Amyloidosis (HATTR) Report Years Considered
Figure 10. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Region: 2021 VS 2028
Figure 13. Global Hereditary Transthyretin Amyloidosis (HATTR) Market Share by Players in 2021
Figure 14. Global Top Hereditary Transthyretin Amyloidosis (HATTR) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Transthyretin Amyloidosis (HATTR) as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Hereditary Transthyretin Amyloidosis (HATTR) Revenue in 2021
Figure 16. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY (2017-2028) & (US$ Million)
Figure 17. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2017-2028)
Figure 18. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2017-2028)
Figure 19. North America Hereditary Transthyretin Amyloidosis (HATTR) Market Size Share by Country (2017-2028)
Figure 20. United States Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY (2017-2028) & (US$ Million)
Figure 23. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2017-2028)
Figure 24. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2017-2028)
Figure 25. Europe Hereditary Transthyretin Amyloidosis (HATTR) Market Size Share by Country (2017-2028)
Figure 26. Germany Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2017-2028)
Figure 34. Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2017-2028)
Figure 35. Asia Pacific Hereditary Transthyretin Amyloidosis (HATTR) Market Size Share by Region (2017-2028)
Figure 36. China Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Japan Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. South Korea Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Southeast Asia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. India Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Australia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 42. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY (2017-2028) & (US$ Million)
Figure 43. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2017-2028)
Figure 44. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2017-2028)
Figure 45. Latin America Hereditary Transthyretin Amyloidosis (HATTR) Market Size Share by Country (2017-2028)
Figure 46. Mexico Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Brazil Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Middle East & Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY (2017-2028) & (US$ Million)
Figure 49. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Type (2017-2028)
Figure 50. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Market Share by Application (2017-2028)
Figure 51. Middle East and Africa Hereditary Transthyretin Amyloidosis (HATTR) Market Size Share by Country (2017-2028)
Figure 52. Turkey Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. UAE Hereditary Transthyretin Amyloidosis (HATTR) Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Pfizer Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022)
Figure 56. Alnylam Pharmaceuticals Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022)
Figure 57. Akcea Therapeutics Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022)
Figure 58. Prothena Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022)
Figure 59. Lonis Pharmaceuticals Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022)
Figure 60. Eidos Therapeutics Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022)
Figure 61. Corino Therapeutics Inc Revenue Growth Rate in Hereditary Transthyretin Amyloidosis (HATTR) Business (2017-2022)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Industry Market Size
